Latest Updates
Progress in medical technologies comes from the brightest minds in the field. Every year a new generation of medical students take the…
SAN CARLOS, Calif. – BioCardia®, Inc. [Nasdaq: BCDA] a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, welcomes Krisztina Zsebo, Ph.D., a 31-year veteran…
Some very significant news was reported at September’s Transcatheter Cardiovascular Therapeutics (TCT) meeting, a preeminent professional meeting for interventional cardiology. Gregg Stone,…
Atrial fibrillation is an abnormal condition affecting the cardiac rhythm in which the upper chambers, the atria, lose their normal contractile regularity,…
For many years now, research teams have been experimenting with various stem cell types in the treatment of heart failure and heart…
Dr. Simon H. Stertzer, Professor Emeritus at Stanford University School of Medicine and Chairman of the Board of Directors at BioCardia, recently…
Obstructive sleep apnea (OSA) has been identified for some years. It has very frequently been ignored by much of the lay public,…
The healthcare landscape is constantly changing. New technology, new knowledge, and new ways of thinking are helping us continually move forward and…
In a recent interview, The Sanity Snack spoke with Dr. Simon H. Stertzer about the future of regenerative medicine. Below are highlighted excerpts…